Designed to capture the undervalued growth potential of Japanese smaller companies over the long term
NAV USD 49.39
As of 2021/01/25
USD 0.31 (0.63%)
As of 2021/01/25
Key investment risks: • The Fund invests at least two-thirds in equities or equity-related instruments of small capitalisation Japanese companies falling within the bottom 25% of their relevant market by way of market capitalisation. • Investments involve varying degree of investment risks (e.g. liquidity, market, economic, political, regulatory, taxation, financial,
interest rate, hedging and currency risks). In extreme market conditions, you may lose your entire investment. • Investments in financial derivatives instruments (“FDIs”) (such as futures, options, forwards and warrants) involve specific risks (e.g. counterparty, liquidity, leverage, volatility, valuation and over-the-counter transaction risk). The Fund may use FDIs to reduce risk and to manage the Fund more efficiently. • The Fund's investments are concentrated in Japan and may subject to higher concentration risk. • The investment decision is yours. If you are in any doubt about the contents of this document, you should seek independent professional financial advice. • Investors should not only base on this document alone to make investment decisions and should read the offering documents including the risk factors for further details.
The investment objective of the Japanese Smaller Companies Fund is to seek long-term capital appreciation by investing at least two-thirds of its total assets in smaller Japanese companies. For this purpose, companies falling within the bottom 25% of their relevant market by way of market capitalisation are considered to be smaller companies. The Fund may invest in OTC markets. Such markets are geographically de-centralised and may be operated and regulated differently from other markets and accordingly may be subject to slightly more risks.
ABOUT THIS FUND
Positioned to benefit from a recovery in Japan’s economy and improving corporate governance to generate long-term capital appreciation
High-conviction strategy leveraging more than 40 years’ experience in Japanese equities
Invests in the smallest 25% of listed Japanese companies by market capitalisation, which the team believes are set to benefit most from a domestic recovery